Myriad Genetics

Balaji's clinical genomics company exited for $300 million

Sam notes that Balaji's first company, Counsyl (a clinical genomics testing company later folded into Myriad Women's Health), was acquired in a roughly $300 million exit.

“sorry, actually, that was like a $300 million exit or something. Yeah, yeah, yeah. Wow, like, like pretty wildly successful.”